Home - Australian Pharmacist

Finding the missing millions with CKD

AP Staff - October 9, 2000

Industry

References Kidney Health Australia. Symptoms of kidney disease. At: https://kidney.org.au/your-kidneys/what-is-kidney-disease/symptoms-of-kidney-disease National Kidney Foundation. Pharmacists and chronic kidney disease. At: https://www.kidney.org/professionals/ckdintercept/pharmacists-and-chronic-kidney-disease Kidney Health Australia. Kidney...

NSAIDs for older people, handle with care

AP Staff - October 9, 2000

Industry

References Chan ASL, Saha S, Weeks GR, Taylor S, Whitty JA, Veerman JL, et al. Cost-effectiveness of a multidisciplinary team approach to the prevention...

Adrenal insufficiency: recognition, management and lifelong support

Vincent Ng - October 9, 2000

CPD

Adrenal insufficiency occurs when the adrenal glands don’t produce sufficient cortisol, a key hormone involved in metabolism and the body’s stress response.

Going bananas over potassium

AP Staff - October 9, 2000

Clinical

Rossi S, ed. Australian medicines handbook. Adelaide: Australian Medicines Handbook; 2025 eTG complete. Melbourne: Therapeutic Guidelines; 2025 Sansom LN, ed. Australian pharmaceutical formulary...

Summer of fun?

AP Staff - November 28, 2000

Advertorial

Whitfield’s ointment

AP Staff - October 9, 2000

Clinical

Homei A, Worboys M. Fungal Disease in Britain and the United States 1850–2000: Mycoses and Modernity. Chapter 2: Athlete’s foot: a disease of...

1...310311312 313 Page 311 of 313

Why endorse pharmacist prescribing?

Will the endorsement support harmonisation?

How can pharmacists define their individual scope of practice?

How will pharmacists become Endorsed Pharmacist Prescribers?

What’s the evidence for pharmacist prescribing?

What are the cost benefits?

How will the endorsement bring Australia in line with international best practice?

Ozempic return leads to medicine double-ups

Discontinuations leave some patients without options

Finding the right therapeutic approach

Which spacers are better?

Do all inhalers fit into a spacer?

Which devices don’t need spacers?

Who needs to use a mask with a spacer?

What’s the big takeaway?

References

2025 PSA Queensland Pharmacist of the Year – Peter Fairgray MPS

Queensland Early Career Pharmacist of the Year – Gift Sailim MPS

Queensland Intern of the Year – Kaden Collier MPS

Queensland Lifetime Achievement Award 2025 – Dr Danielle Stowasser MPS

Professor James Dare Pharmacy Graduate of the Year – Tahlia O’Hara

Redefining value

Building relationships and trust

The march of AI

Why endorse pharmacist prescribing?

Will the endorsement support harmonisation?

How can pharmacists define their individual scope of practice?

How will pharmacists become Endorsed Pharmacist Prescribers?

What’s the evidence for pharmacist prescribing?

What are the cost benefits?

How will the endorsement bring Australia in line with international best practice?

Ozempic return leads to medicine double-ups

Discontinuations leave some patients without options

Finding the right therapeutic approach

Which spacers are better?

Do all inhalers fit into a spacer?

Which devices don’t need spacers?

Who needs to use a mask with a spacer?

What’s the big takeaway?

References

2025 PSA Queensland Pharmacist of the Year – Peter Fairgray MPS

Queensland Early Career Pharmacist of the Year – Gift Sailim MPS

Queensland Intern of the Year – Kaden Collier MPS

Queensland Lifetime Achievement Award 2025 – Dr Danielle Stowasser MPS

Professor James Dare Pharmacy Graduate of the Year – Tahlia O’Hara

Redefining value

Building relationships and trust

The march of AI

Why endorse pharmacist prescribing?

Will the endorsement support harmonisation?

How can pharmacists define their individual scope of practice?

How will pharmacists become Endorsed Pharmacist Prescribers?

What’s the evidence for pharmacist prescribing?

What are the cost benefits?

How will the endorsement bring Australia in line with international best practice?

Ozempic return leads to medicine double-ups

Discontinuations leave some patients without options

Finding the right therapeutic approach

Which spacers are better?

Do all inhalers fit into a spacer?

Which devices don’t need spacers?

Who needs to use a mask with a spacer?

What’s the big takeaway?

References

2025 PSA Queensland Pharmacist of the Year – Peter Fairgray MPS

Queensland Early Career Pharmacist of the Year – Gift Sailim MPS

Queensland Intern of the Year – Kaden Collier MPS

Queensland Lifetime Achievement Award 2025 – Dr Danielle Stowasser MPS

Professor James Dare Pharmacy Graduate of the Year – Tahlia O’Hara

Redefining value

Building relationships and trust

The march of AI

Why endorse pharmacist prescribing?

Will the endorsement support harmonisation?

How can pharmacists define their individual scope of practice?

How will pharmacists become Endorsed Pharmacist Prescribers?

What’s the evidence for pharmacist prescribing?

What are the cost benefits?

How will the endorsement bring Australia in line with international best practice?

Ozempic return leads to medicine double-ups